Solvent wind-down · IBC Section 59
Daiichi Sankyo India Pharma Private Limited
U24233HR2007PTC044362 · Company
Liquidation outcome · IBC s.59
Realisation of assets
₹273.64 Cr
Amount due to creditors
₹2.35 Cr
Amount paid to creditors
₹2.35 Cr
Liquidation expenses
₹29.80 Cr
Surplus to members
₹241.49 Cr
Time to dissolve
1,582 days
Commenced
7 Sep 2017
Dissolved
6 Jan 2022
Solvent voluntary liquidation under IBC Section 59 — a healthy company choosing to wind up. Creditors are paid in full and costs met before any surplus returns to members; there is no haircut or acquirer.
Here, ₹241.49 Cr in surplus was returned to members.
Company · MCA master
MCA status
Dissolved (Liquidated)
Company class
Private
Category
Company limited by shares
Sub-category
Non-government company
Listing
Unlisted
Incorporated
13 Mar 2007
Authorised capital
₹178.00 Cr
Paid-up capital
₹177.00 Cr
ROC
ROC Delhi
Industry
Manufacturing (Metals and Chemicals, and products thereof)
PIN
122002
Registered office
Unit 62, Level 18, One Horizon Center, Golf Course Road, DLF Phase 5, Sector-4,3,Gurgaon,Gurgaon,Haryana,122002-India
Full voluntary-liquidation records — realisation, payout and surplus across every quarter — are available to members.
Request access →